report banner

News in English

PostNews

Scientists at UCSF-PHI Center of Excellence map the genetic progression of invasive skin cancer

Utilizing precision genetic engineering and PHI’s HoloMonitor technology, scientists at University of California, San Francisco, have for the first time been able to monitor and map how mutations break down the genetic protection against skin cancer.
Learn more …
PostNews
App Suite Banner

PHI´s new software available for customer delivery

In this first version of App Suite three common analyzes are included: cell proliferation, cell motility, and cell quality control. App Suite will be rapidly expanded with additional applications. HoloMonitor® App Suite 2.0 is scheduled to be released to customers in Q4 2018.
Learn more …
PostPress Release

Kommuniké från extra bolagsstämma i Phase Holographic Imaging PHI AB (publ)

Igår, den 18 juni 2018, hölls extra bolagsstämma i Phase Holographic Imaging PHI AB (publ). Stämman röstande enhälligt för föreslagna beslut gällande nyemission.
Learn more …
PostNews: Press Release

PHI and BioSpherix sign co-marketing agreement

Phase Holographic Imaging (PHI) and BioSpherix recently signed a collaboration agreement aiming to co-market the companies’ complementary product lines. BioSpherix, NY USA, manufactures and markets advanced cell incubators.
Learn more …
PostNews

Biostock interview with CEO Peter Egelberg

Learn more …
PostNews
QUT_scientists_HoloMonitor_Twitter

New CEO commentary — “Redefining aging with HoloMonitor”

In the CEO commentary “Redefining aging with HoloMonitor” Peter Egelberg comments on the promising research results that were recently reported by Australian television.
Learn more …
1171819202130